BME100 f2014:Group33 L2

BME 100 Fall 2014	Home People Lab Write-Up 1 | Lab Write-Up 2 | Lab Write-Up 3 Lab Write-Up 4 | Lab Write-Up 5 | Lab Write-Up 6 Course Logistics For Instructors Photos Wiki Editing Help
OUR TEAM Name: Emigdio Ruiz Esquivel Name: John Cunningham Name: Wandasun Sihenath Name: Chris Adams Name: Tim Snelling Name: Breanna Falcon LAB 2 WRITE-UP Descriptive Statistics Experiment 1 (Rats) Experiment 2 (Humans) Results Experiment 1 (Rats) ‎Experiment 2 (Humans) Analysis Experiment 1 Rats Experiment 2 Humans We used a t-test for the rats because they can be monitored when given the dosage and also because we are estimating the standard deviation based off of the sample data and so it accounts for the extra variability, since the data points might differ from each other. The Anova test was used on the humans in order to see what the differences in the variables were in the numerical data which would be able to show if the increase of inflammotin protein was attributed to the dosage that was given to both the humans and rats. Summary/Discussion The results indicated that the inflammotin protein increased in both rats and humans as the dosage increased. However, the extent to which the dosage affected each test group varied. In the rats, the inflammotin levels increased from just above 10 pg/ml to approximately 11 pg/ml after changing the dosage from 5mg to 10mg. The effect of LPS on Humans was higher when compared to the rat scale since rats and humans have different body structures and do not function in the same way. There was a significant jump in the human body just by changing the dosage from 10mg to 15mg. The standard error is also higher in humans than rats because the rats can be contained, meaning they can be properly monitored. Whereas in humans, the standard error is greater because they could be doing other things such as: taking medication, vitamins or eating certain foods, introducing a far greater number of variables that could affect the experiment and skew the data.